Turnstone Biologics Inc. logo

Turnstone Biologics Inc.

Turnstone Biologics is a biotechnology company, focused on developing novel oncolytic viral immunotherapies for cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://turnstonebio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
787 Bank Street, 2nd Floor, K1S 3V5
Ottawa
Canada
Email
Contact Number
+1 613-421-8930

Turnstone Biologics is a biotechnology company, focused on developing novel oncolytic viral immunotherapies for cancer.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/turnstone-biologics” connections=”true” suffix=””]

Turnstone is developing first-in-class Maraba Oncolytic Virus based immunotherapy, that combines a bioselected and engineered virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses of unprecedented magnitude.

In Oct 2015, Turnstone Biologics announced the completion of an $11.3 Mn Series A financing round led by Versant Ventures with follow-on capital committed in excess of $20.0 Mn. Founding investor FACIT also participated in the round.